|
|
???tair.name??? >
???browser.page.title.author???
|
"yen fs"???jsp.browse.items-by-author.description???
Showing items 1-25 of 90 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2025-09-15 |
Income and wealth inequality is associated with young-onset type 2 diabetes
|
Yen, FS;Wei, JC;Hung, YM;Liu, JS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-09-12 |
Impact of adding GLP-1 receptor agonists to insulin therapy on cardiovascular and microvascular outcomes in type 2 diabetes: A nationwide cohort study from Taiwan
|
Yen, FS;Wei, JC;Sung, CY;Li, PY;Tsai, FJ;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2025-08-05 |
Diabetic microvascular disease and risk of peripheral artery disease, foot Ulcer, leg infection, and amputation
|
Yen, FS;Yen, YH;Hung, YM;Wei, JC;Tsai, FJ;Hung, YT;Lin, HJ;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-08 |
Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes
|
Yen, FS;Wei, JCC;Huang, YH;Li, PY;Tsai, FJ;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2025-08 |
Impact of SGLT2 inhibitors on kidney health and survival in patients with polycystic kidney disease and type 2 diabetes
|
Yen, FS;Huang, JY;Dong, C;Hwu, CM;Hsu, CC;Wei, JCC |
| 國家衛生研究院 |
2025-07-22 |
Sodium-glucose cotransporter 2 inhibitors use in patients with liver cirrhosis
|
Yen, FS;Hou, MC;Wei, JCC;Huang, YH;Shih, YH;Pan, CW;Wang, ST;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-06-02 |
Association of DPP-4 inhibitors with respiratory and cardiovascular complications in patients with COPD: A nationwide cohort study
|
Yen, FS;Wei, JCC;Ko, FS;Huang, YH;Yip, HT;Tsai, FJ;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-06 |
SGLT-2 inhibitors and the risk of chronic obstructive pulmonary disease exacerbations and mortality in chronic obstructive pulmonary disease patients
|
Yen, FS;Wei, JCC;Huang, YH;Hsu, TJ;Wang, ST;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-05-23 |
Microvascular complications and cancer risk in type 2 diabetes: A population-based study
|
Yen, YH;Wei, JCC;Yen, FS;Kao, YS;Lin, HJ;Cho, DY;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-05 |
Sodium-glucose cotransporter2 inhibitors and associated liver-related outcomes in diabetes patients
|
Yen, FS;Wei, JCC;Wang, C;Hou, MC;Yu, TS;Huang, YH;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-03-21 |
The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes
|
Yen, FS;Hsu, CC;Yeh, YK;Cheng, WY;Liao, PL;Hwu, CM;Cheng-Chung Wei, J |
| 國家衛生研究院 |
2025-02-25 |
Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes
|
Yen, FS;Hung, YM;Huang, JY;Hsu, CC;Cheng, WY;Hwu, CM;Wei, JCC |
| 國家衛生研究院 |
2025-02-12 |
SGLT-2 inhibitors and the risk of COPD exacerbations and mortality in COPD patients
|
Yen, FS;Wei, JC;Huang, YH;Hsu, TJ;Wang, ST;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-02 |
The impact of pay-for-performance care on the mortality and cardiovascular outcomes in older adults with newly diagnosed type 2 diabetes: a nationwide population-based cohort study
|
Yen, FS;Wei, JCC;Lin, SY;Hsu, J;Yeh, YK;Huang, YH;Hsu, TJ;Cho, DY;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-01-27 |
Low birth weight and chronic kidney disease with progression to kidney failure in children
|
Yen, FS;Wei, JC;Cheng, WY;Huang, CT;Wu, YL;Teh, SH;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2024-11-14 |
Impact of family income on the development of gestational diabetes mellitus and the associated birth outcomes: A nationwide study
|
Yen, FS;Wei, JCC;Wu, YL;Lo, YR;Chen, CM;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2024-1016 |
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
|
Yen, FS;Hsu, CC;Wei, JCC;Tsai, FJ;Huang, YH;Yu, TS;Hwu, CM |
| 國家衛生研究院 |
2024-09-10 |
The effect of sodium-glucose cotransporter-2 inhibitors on graft survival and cardiorenal outcomes in patients with diabetes and heart transplantation
|
Hwu, CM;Yen, FS;Huang, JY;Hsu, CC;Cheng, WY;Wei, JC |
| 國家衛生研究院 |
2024-08-29 |
Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan
|
Yen, YH;Yen, FS;Ko, FS;Wei, JCC;Huang, YH;Yu, TS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2024-08-08 |
Glucagon-like peptide-1 receptor agonists and risk of sight-threatening retinopathy in Taiwanese population: A propensity based cohort study
|
Yen, FS;Wei, JC;Shih, YH;Hung, YT;Hsu, TJ;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2024-06-12 |
Sodium-glucose cotransporter-2 inhibitors and nephritis among patients with systemic lupus erythematosus
|
Yen, FS;Wang, SI;Hsu, CC;Hwu, CM;Wei, JCC |
| 國家衛生研究院 |
2024-04-30 |
Sodium-glucose cotransporter-2 inhibitors and the risk for dialysis and cardiovascular disease in patients with stage 5 chronic kidney disease
|
Yen, FS;Hwu, CM;Liu, JS;Wu, YL;Chong, K;Hsu, CC |
| 國家衛生研究院 |
2024-04 |
Metformin and the risks of cellulitis, foot infections, and amputation in patients with type 2 diabetes
|
Yeh, YK;Yen, FS;Wei, JC;Hu, KC;Yu, TS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2024-01-04 |
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
|
Yen, FS;Hou, MC;Wei, JCC;Shih, YH;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-12-20 |
Sodium-glucose cotransporter 2 inhibitors and risk of retinopathy in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Yu, TS;Hung, YT;Hsu, CC;Hwu, CM |
Showing items 1-25 of 90 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
|
